The Pharmacologic Management of Heart Disease, Page 536Joel Kupersmith, Prakash C. Deedwania |
Contents
Principles and Practice of Pharmacotherapy | 3 |
PART II | 34 |
LipidLowering Drugs | 41 |
Copyright | |
16 other sections not shown
Common terms and phrases
ACE inhibitors activity acute myocardial infarction administration agents alteplase amiodarone angioplasty antiarrhythmic drugs anticoagulation aspirin associated atherosclerosis atrial fibrillation B-blockers bile acid blood pressure calcium channel blockers captopril cardiac cardiovascular cholesterol level chronic Circulation Clin clinical trials Coll Cardiol congestive heart failure death decreased digoxin dilated diltiazem diuretic dosage dose drug therapy effects efficacy ejection fraction embolism enalapril Engl epinephrine evaluated flecainide half-life heart disease heart rate hemodynamic heparin hepatic hypertension increased inhibition intravenous ischemia ischemic LDL cholesterol left ventricular dysfunction lidocaine lipid lipoprotein long-term lovastatin metabolism mg/dL mortality niacin nitrates oral patients pharmacokinetics pharmacologic placebo plasma plasminogen platelet propafenone quinidine receptor reduced renal risk factors secondary prevention serum sinus rhythm sotalol stenosis streptokinase stroke symptomatic symptoms therapeutic thromboembolism thrombolytic therapy thrombus tients tion tissue torsades treated treatment triglyceride unstable angina vascular vasodilator ventricular arrhythmias ventricular function ventricular tachycardia verapamil warfarin